Liu Y, Chen D, Zhao L, Zhang H, Wu S, Chen X
Hum Vaccin Immunother. 2025; 21(1):2455807.
PMID: 39973250
PMC: 11845052.
DOI: 10.1080/21645515.2025.2455807.
Feng Y, van Bodegraven D, Kadek A, L B Munguira I, Soria-Martinez L, Nentwich S
Nat Commun. 2024; 15(1):10076.
PMID: 39572555
PMC: 11582657.
DOI: 10.1038/s41467-024-54373-0.
Jin J, Li S, Huang H, Li J, Lyu Y, Ran Y
Exp Ther Med. 2024; 28(4):382.
PMID: 39161614
PMC: 11332130.
DOI: 10.3892/etm.2024.12671.
Shin M, Jung E, Moreno-Gonzalez M, Ortega-Rivera O, Steinmetz N
Bioeng Transl Med. 2024; 9(1):e10574.
PMID: 38193118
PMC: 10771553.
DOI: 10.1002/btm2.10574.
Cacciotto C, Dore G, Anfossi A, Tore G, Varoni M, Demontis M
Vet Res Commun. 2022; 47(2):641-649.
PMID: 36331789
PMC: 10209267.
DOI: 10.1007/s11259-022-10018-5.
Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity.
Chabeda A, van Zyl A, Rybicki E, Hitzeroth I
Front Plant Sci. 2019; 10:779.
PMID: 31281327
PMC: 6597877.
DOI: 10.3389/fpls.2019.00779.
A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model.
Yin F, Wang Y, Chen N, Jiang D, Qiu Y, Wang Y
Papillomavirus Res. 2017; 3:85-90.
PMID: 28720462
PMC: 5883244.
DOI: 10.1016/j.pvr.2017.02.005.
Molecular mechanisms of HPV mediated neoplastic progression.
Senapati R, Senapati N, Dwibedi B
Infect Agent Cancer. 2016; 11:59.
PMID: 27933097
PMC: 5123406.
DOI: 10.1186/s13027-016-0107-4.
Peptidic inhibitors for in vitro pentamer formation of human papillomavirus capsid protein l1.
Fu D, Jin S, Zheng D, Zha X, Wu Y
ACS Med Chem Lett. 2015; 6(4):381-5.
PMID: 25893037
PMC: 4394338.
DOI: 10.1021/ml500392y.
Prevalence of human papillomavirus variants and genetic diversity in the L1 gene and long control region of HPV16, HPV31, and HPV58 found in North-East Brazil.
Gurgel A, Chagas B, do Amaral C, Nascimento K, Leal L, Silva Neto J
Biomed Res Int. 2015; 2015:130828.
PMID: 25793187
PMC: 4352477.
DOI: 10.1155/2015/130828.
Characterization of an RNA aptamer against HPV-16 L1 virus-like particles.
Leija-Montoya A, Benitez-Hess M, Toscano-Garibay J, Alvarez-Salas L
Nucleic Acid Ther. 2014; 24(5):344-55.
PMID: 25111024
PMC: 4162430.
DOI: 10.1089/nat.2013.0469.
Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11.
Gall T, Kis A, Tatar T, Kardos G, Gergely L, Szarka K
Med Microbiol Immunol. 2013; 202(5):353-63.
PMID: 23649705
DOI: 10.1007/s00430-013-0297-y.
Multiscale macromolecular simulation: role of evolving ensembles.
Singharoy A, Joshi H, Ortoleva P
J Chem Inf Model. 2012; 52(10):2638-49.
PMID: 22978601
PMC: 3721968.
DOI: 10.1021/ci3002952.
Hierarchical Order Parameters for Macromolecular Assembly Simulations I: Construction and Dynamical Properties of Order Parameters.
Singharoy A, Sereda Y, Ortoleva P
J Chem Theory Comput. 2012; 8(4):1379-1392.
PMID: 22661911
PMC: 3361912.
DOI: 10.1021/ct200574x.
Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.
Matic S, Rinaldi R, Masenga V, Noris E
BMC Biotechnol. 2011; 11:106.
PMID: 22085463
PMC: 3248878.
DOI: 10.1186/1472-6750-11-106.
Multiscale simulation of microbe structure and dynamics.
Joshi H, Singharoy A, Sereda Y, Cheluvaraja S, Ortoleva P
Prog Biophys Mol Biol. 2011; 107(1):200-17.
PMID: 21802438
PMC: 3383072.
DOI: 10.1016/j.pbiomolbio.2011.07.006.
Structural basis of oligosaccharide receptor recognition by human papillomavirus.
Dasgupta J, Bienkowska-Haba M, Ortega M, Patel H, Bodevin S, Spillmann D
J Biol Chem. 2010; 286(4):2617-24.
PMID: 21115492
PMC: 3024757.
DOI: 10.1074/jbc.M110.160184.
Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres.
Murata Y, Lightfoote P, Rose R, Walsh E
Virol J. 2009; 6:81.
PMID: 19538743
PMC: 2702290.
DOI: 10.1186/1743-422X-6-81.
Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity.
Schadlich L, Senger T, Gerlach B, Mucke N, Klein C, Bravo I
J Virol. 2009; 83(15):7690-705.
PMID: 19457985
PMC: 2708645.
DOI: 10.1128/JVI.02588-08.
New variants of human papillomavirus type 18 identified in central Brazil.
Cerqueira D, Raiol T, Veras N, Milanezi N, Amaral F, Brigido M
Virus Genes. 2008; 37(2):282-7.
PMID: 18663566
DOI: 10.1007/s11262-008-0263-8.